Ayrton Capital’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Ayrton Capital’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-74,600	Closed	-$751K	–	102
2022 Q4	$751K	Hold	74,600	–	–	2.05%	21
2022 Q3	$739K	Hold	74,600	–	–	1.3%	29
2022 Q2	$730K	Hold	74,600	–	–	1.19%	27
2022 Q1	$730K	Hold	74,600	–	–	0.95%	38
2021 Q4	$725K	Buy	+74,600	New	+$725K	0.68%	45

Ayrton Capital's MSAC Position: Q1 2023 in Review

Ayrton Capital sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 74,600 shares — an estimated $751K sold.

Ayrton Capital first reported a position in MSAC in Q4 2021 and held it in 5 quarters. The position peaked at $751K in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Ayrton Capital reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Ayrton Capital sold 74,600 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $751K.
Ayrton Capital first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q4 2021 and held it in 5 quarters.
Ayrton Capital's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $751K in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Ayrton Capital's 13F filing for Q1 2023, filed 12 May 2023.